Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer : significance of pre-treatment and post-resection RAS mutations
Citation
Gollins , S , West , N , Sebag-Montefiore , D , Myint , A S , Saunders , M , Susnerwala , S , Quirke , P , Essapen , S , Samuel , L , Sizer , B , Worlding , J , Southward , K , Hemmings , G , Tinkler-Hundal , E , Taylor , M , Bottomley , D , Chambers , P , Lawrie , E , Lopes , A & Beare , S 2017 , ' Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer : significance of pre-treatment and post-resection RAS mutations ' , British Journal of Cancer , vol. 117 , pp. 1286-1294 . https://doi.org/10.1038/bjc.2017.294
Rights
© The Author(s) named above. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/